THE PEER-REVIEWED FORUM FOR EVIDENCE IN BENEFIT DESIGN ™ JANUARY 2009
VOLUME 2, NUMBER 1
EDITORIAL
Healthcare Innovation Viability: On the Edge of a Knife Robert E. Henry
Why Financial Incentives Aren’t Enough to Move the Needle on Compliance Emily Cox, PhD BUSINESS ™
Prescription Copay Reduction Program for Diabetic Employees: Impact on Medication Compliance and Healthcare Costs and Utilization Kavita V. Nair, PhD; Kerri Miller, PharmD, BCPS; Joseph Saseen, PharmD, FCCP, BCPS; Pamela Wolfe, MS; Richard Read Allen, MS; Jinhee Park, CPhil, MA, MS Stakeholder Perspective by Geoffrey P. Cole, MD, MBA CLINICAL
Partial Compliance with Antipsychotics Increases Mental Health Hospitalizations in Schizophrenic Patients: Analysis of a National Managed Care Database Chris M. Kozma, PhD; Peter J. Weiden, MD Stakeholder Perspective by Paul Anthony Polansky, BSPharm, MBA
Alzheimer’s Disease: A Healthcare Burden of Epidemic Proportion T.S. Dharmarajan, MD, FACP, AGSF; Srinivas G. Gunturu, MD Stakeholder Perspective by Jeffrey Januska, PharmD DEPARTMENTS ◆ Generic Drug Trends ◆ AHA Meeting Highlights
©2009 Engage Healthcare Communications, LLC www.AHDBonline.com